AG12992/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1996	1
1997	6
1998	8
1999	11
2000	2
2001	5
2002	6
2003	8
2004	6
2005	2
2024	0

1

A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.

Shults CW, Haas RH, Beal MF. Shults CW, et al. Biofactors. 1999;9(2-4):267-72. doi: 10.1002/biof.5520090223. Biofactors. 1999. PMID: 10416040 Review.

2

Coenzyme Q10 as a possible treatment for neurodegenerative diseases.

Beal MF. Beal MF. Free Radic Res. 2002 Apr;36(4):455-60. doi: 10.1080/10715760290021315. Free Radic Res. 2002. PMID: 12069110 Review.

3

Distribution of glutamate transporter subtypes during human brain development.

Bar-Peled O, Ben-Hur H, Biegon A, Groner Y, Dewhurst S, Furuta A, Rothstein JD. Bar-Peled O, et al. J Neurochem. 1997 Dec;69(6):2571-80. doi: 10.1046/j.1471-4159.1997.69062571.x. J Neurochem. 1997. PMID: 9375691 Free article.

4

Translating therapies for Huntington's disease from genetic animal models to clinical trials.

Hersch SM, Ferrante RJ. Hersch SM, et al. NeuroRx. 2004 Jul;1(3):298-306. doi: 10.1602/neurorx.1.3.298. NeuroRx. 2004. PMID: 15717031 Free PMC article. Review.

5

Cytochrome C and caspase-9 expression in Huntington's disease.

Kiechle T, Dedeoglu A, Kubilus J, Kowall NW, Beal MF, Friedlander RM, Hersch SM, Ferrante RJ. Kiechle T, et al. Neuromolecular Med. 2002;1(3):183-95. doi: 10.1385/NMM:1:3:183. Neuromolecular Med. 2002. PMID: 12095160

6

Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.

Beal MF. Beal MF. Biofactors. 1999;9(2-4):261-6. doi: 10.1002/biof.5520090222. Biofactors. 1999. PMID: 10416039 Review.

7

Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.

Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G. Mattiazzi M, et al. J Biol Chem. 2002 Aug 16;277(33):29626-33. doi: 10.1074/jbc.M203065200. Epub 2002 Jun 5. J Biol Chem. 2002. PMID: 12050154 Free article.

8

Increased CSF F2-isoprostane concentration in probable AD.

Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Neurology. 1999 Feb;52(3):562-5. doi: 10.1212/wnl.52.3.562. Neurology. 1999. PMID: 10025788

9

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis.

Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. Beal MF, et al. Ann Neurol. 1997 Oct;42(4):644-54. doi: 10.1002/ana.410420416. Ann Neurol. 1997. PMID: 9382477

10

Cultured motor neurons possess calcium-permeable AMPA/kainate receptors.

Bar-Peled O, O'Brien RJ, Morrison JH, Rothstein JD. Bar-Peled O, et al. Neuroreport. 1999 Mar 17;10(4):855-9. doi: 10.1097/00001756-199903170-00034. Neuroreport. 1999. PMID: 10208560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year